PERIPHERAL VASCULAR HAEMATOMA

PERIPHERAL VASCULAR HAEMATOMA was reported 18 times

PERIPHERAL VASCULAR HAEMATOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Guanylate Cyclase-C Agonist [EPC] 2 0.0010
1 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
2 Thiazide-like Diuretic [EPC] 2 0.0000
3 PCSK9 Inhibitor [EPC] 1 0.0000
4 Provitamin D2 Compound [EPC] 1 0.0000
5 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1 0.0000
6 Fluoroquinolone Antibacterial [EPC] 4 0.0000
7 Prostacycline Vasodilator [EPC] 4 0.0000
8 Cardiac Glycoside [EPC] 2 0.0000
9 Factor Xa Inhibitor [EPC] 7 0.0000
10 P2Y12 Platelet Inhibitor [EPC] 3 0.0000
11 Loop Diuretic [EPC] 11 0.0000
12 Phosphodiesterase 5 Inhibitor [EPC] 3 0.0000
13 Endothelin Receptor Antagonist [EPC] 4 0.0000
14 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
15 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
16 alpha-Adrenergic Blocker [EPC] 2 0.0000
17 Osmotic Laxative [EPC] 4 0.0000
18 Aldosterone Antagonist [EPC] 2 0.0000
19 Arteriolar Vasodilator [EPC] 1 0.0000
20 Catecholamine [EPC] 1 0.0000
21 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
22 Integrin Receptor Antagonist [EPC] 1 0.0000
23 Amide Local Anesthetic [EPC] 1 0.0000
24 Nitrate Vasodilator [EPC] 1 0.0000
25 Purine Antimetabolite [EPC] 1 0.0000
26 Antiarrhythmic [EPC] 1 0.0000
27 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
28 Benzodiazepine [EPC] 5 0.0000
29 Platelet Aggregation Inhibitor [EPC] 4 0.0000
30 beta-Adrenergic Blocker [EPC] 2 0.0000
31 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
32 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
34 Kinase Inhibitor [EPC] 2 0.0000
35 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
36 Corticosteroid [EPC] 3 0.0000
37 GLP-1 Receptor Agonist [EPC] 1 0.0000
38 Insulin Analog [EPC] 1 0.0000
39 Proton Pump Inhibitor [EPC] 1 0.0000